Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
SGRL
₹633
₹600.00
₹684.00
Data is not available
Markets Today
Historical Performance
As of 31-07-2026 02:28, Shree Ganesh Remedies Ltd. share price today is ₹0, with a change of ₹-654.20 (-100.00%) from the previous close of ₹654.2. The stock opened at ₹659.7 and traded between ₹600 and ₹684, with a total traded volume of 18670 shares. The company has a market capitalization of ₹842 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹759 and ₹381.1, respectively.
Shree Ganesh Remedies Ltd. valuation metrics include a P/E ratio of 47.4, EPS of ₹13.83, and book value of ₹5.20. Profitability indicators show ROE of 10.89%. Shree Ganesh Remedies Ltd. has reported revenue of ₹109.29 Cr and net profit of ₹17.76 Cr.
Shree Ganesh Remedies Ltd. technical indicators include Day RSI at 51.97, Day MFI at 30.11, Day ADX at 15.85. Additional indicators include Commodity Channel Index (CCI) at -60.2 and Williams %R at -45.8. Momentum indicators show Day MACD at -1.54, Day MACD Signal Line at 3.62, DayATR at 39.37. Rate of Change indicators for Shree Ganesh Remedies Ltd. include ROC125 at 63.39 and ROC21 at -2.63.
Exponential moving averages include EMA5 at ₹637.9, EMA10 at ₹642.7, EMA12 at ₹644.4, EMA20 at ₹647.2, EMA26 at ₹645.9, EMA50 at ₹628.2, EMA100 at ₹590.4, EMA200 at ₹566.5. Simple moving averages include SMA5 at ₹634.2, SMA10 at ₹641.8, SMA20 at ₹656.4, SMA30 at ₹660.2, SMA50 at ₹643, SMA100 at ₹570, SMA150 at ₹532.7, SMA200 at ₹518.2.
Support levels for Shree Ganesh Remedies are placed at First Support ₹623.50, Second Support ₹592.80, Third Support ₹574.55. Resistance levels are seen at First Resistance ₹672.45, Second Resistance ₹690.70, Third Resistance ₹721.40. Shree Ganesh Remedies Ltd. shareholding pattern shows promoter holding at 72.84%, FII holding at 0%, DII holding at 0%, public holding at 26.65%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 33.20 | 21.11 | 30.32 | 24.67 | 24.43 |
| Operating Expense | 21.82 | 14.38 | 20.70 | 17.37 | 14.55 |
| Operating Profit | 11.37 | 6.73 | 9.62 | 7.30 | 9.88 |
| Depreciation | 2.80 | 2.67 | 2.59 | 2.42 | 2.42 |
| Interest | 0.88 | 0.74 | 1.01 | 0.94 | 0.96 |
| Tax | 2.45 | 0.89 | 1.76 | 1.15 | 2.18 |
| Net Profit | 6.27 | 3.10 | 4.96 | 3.45 | 6.60 |
₹633.00
↗ Bullish Moving Average
14
↘ Bearish Moving Average
2
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 72.8 | 72.8 | 72.8 | 72.8 | 72.8 | 72.8 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0.5 |
| Public | 27.2 | 27.2 | 27.2 | 27.2 | 27.2 | 26.6 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 3.44 K | 4.01 K | 85.68% |
| Week | 3.24 K | 4.18 K | 77.54% |
| 1 Month | 4.22 K | 6.04 K | 69.86% |
| 6 Month | 5.75 K | 8.15 K | 70.46% |
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Expensive Performers (DVM)
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Negative to Positive growth in Sales and Profit with Strong Price momentum
Biggest Price Gainers from Open
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 07 Sep, 2023 | 0.5 | FINAL | 07 Sep, 2023 | Equity Share |
| 15 Sep, 2022 | 0.5 | FINAL | 16 Sep, 2022 | Equity Share |
| 08 Sep, 2021 | 1.75 | FINAL | 11 Sep, 2021 | Equity Share |
| 01 Sep, 2020 | 1.5 | FINAL | 02 Sep, 2020 | Equity Share |
| 22 Aug, 2019 | 1.25 | FINAL | Equity Share | |
| 19 Sep, 2018 | 1 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹40.40 | ₹545.10 | ₹187 | ₹281 | ₹25 | ₹5.07 |
| % Change | 0.72% | 1.90% | 0.00% | -1.04% | -0.99% | -1.36% |
| Revenue TTM (₹ Cr) | - | - | - | - | ₹1.27 | ₹69.99 |
| Net Profit TTM (₹ Cr) | - | - | - | - | ₹-0.25 | ₹-176.47 |
| PE TTM | 9.40 | - | 12.60 | 40.60 | -59.80 | -0.20 |
| 1 Year Return | 36.47 | 461.11 | 414 | |||
| ROCE | - | 3.56 | - | - | - | -56.37 |
Aptus Pharma Ltd.
₹ 278.50
+3.34%
Amanta Healthcare Ltd.
₹ 168.72
+1.99%
Anlon Healthcare Ltd.
₹ 14.62
+0.69%
Patel Chem Specialities Ltd.
₹ 91.50
+0.49%
Asston Pharmaceuticals Ltd.
₹ 67.00
-0.59%
Amrutanjan Health Care Ltd.
₹ 514.35
-0.32%
Astonea Labs Ltd.
₹ 273.75
+0.00%
Amwill Health Care Ltd.
₹ 42.50
+0.00%
Valiant Laboratories Ltd.
₹ 60.00
-0.55%
Shelter Pharma Ltd.
₹ 26.75
+0.00%
Trident Lifeline Ltd.
₹ 262.00
-2.60%
Dipna Pharmachem Ltd.
₹ 4.56
+7.04%
Achyut Healthcare Ltd.
₹ 6.63
+0.00%
Sigachi Industries Ltd.
₹ 25.92
-1.97%
Windlas Biotech Ltd.
₹ 859.00
-0.10%
Vineet Laboratories Ltd.
₹ 39.74
+2.26%
Chandra Bhagat Pharma Ltd.
₹ 37.92
+4.98%
Solara Active Pharma Sciences Ltd.
₹ 515.00
+1.38%
Rajnish Wellness Ltd.
₹ 0.42
+0.00%
Zim Laboratories Ltd.
₹ 112.99
+1.34%
Bharat Parenterals Ltd.
₹ 1466.95
-0.91%
Medico Remedies Ltd.
₹ 48.99
+3.05%
By signing up I certify terms, conditions & privacy policy